NEW YORK – October 28, 2026 -- Breakthrough T1D, the global type 1 diabetes (T1D) research and advocacy organization, has presented four awards to researchers whose work spans disease prevention, insulin pump therapy, beta cell biology and large-scale clinical trials. The recipients were recognized at a ceremony in Philadelphia earlier in October 2026.

Chief Scientific Officer Sanjoy Dutta, Ph.D., said the honorees embody the organization's mission "to accelerate research toward cures for type 1 diabetes while improving the lives of those who live with it."

Philadelphia – October 12, 2026 -- Breakthrough T1D, formerly JDRF, closed its inaugural Clinical & Research Congress after more than 80 sessions and scheduled the 2027 edition for Washington, D.C., October 15-17, 2027.

The congress ran October 9-11, 2026, in Philadelphia. It brought together clinicians, researchers, scientists, healthcare professionals, industry leaders, people with lived experience and community advocates.

New York – September 16, 2026 -- A consensus paper published in Diabetologia establishes the first international framework for population-wide screening of type 1 diabetes (T1D), setting concrete age thresholds and testing protocols for clinical adoption.